NAV as of 20 Oct 2026, 12:00 AM UTC
$19.24 (9.07%)
Year-To-Date Change
26.61%
LSE
Borsa Italiana
Capital at risk. NAV calculated by Leverage Shares. For more information on the calculation please click here
The Leverage Shares 3x Long UnitedHealth (UNH) ETP (ISIN XS3091985815) is an exchange traded product (ETP) that seeks to deliver three times (3x) the daily performance of UnitedHealth Group Incorporated. It achieves leverage through margin borrowing and has physical ownership of the underlying, so it does not use swaps or other derivatives to achieve its exposure, and it does not have credit risk. Exposure is rebalanced daily, and an intraday rebalance mechanism ("airbag") is designed to cushion the largest intra-day moves, triggering at 16.67%. You cannot lose more than the amount you invest. The Leverage Shares 3x Long UnitedHealth (UNH) ETP has an annual management fee of 0.75% and is listed on the following exchanges: London Stock Exchange, Borsa Italiana. It is designed for short term trading and should be monitored daily.
To seek daily investment results, before fees and expenses, that correspond to 300% (3x) the daily performance of the underlying stock (UNH).
Sophisticated investors and active traders seeking to magnify short-term bullish views or tactically hedge positions, via transparent leverage and without a margin account.
*However, these are complex products.
Value of Underlying Assets
$849,002
or 2,025 shares of UNH
AUM
$282,831
or 14,700 shares of UNH3
Liabilities
$566,170
Passported Countries:
United Kingdom
Italy
Germany
France
Spain
Netherlands
Ireland
Poland
Belgium
Sweden
Norway
Austria
* The information on this website regarding UK Fund Reporting Status is accurate as of the stated effective date (the "Effective Date"). Leverage Shares makes no representation or warranty that such information will remain accurate, complete or current thereafter, assumes no obligation to update it, and, to the fullest extent permitted by applicable law, accepts no responsibility or liability for any inaccuracies or omissions arising after the Effective Date.
Market Insights
UnitedHealth Q1 Earnings Top Estimates and Boosts 2026 Guidance UnitedHealth delivered a solid top- and bottom-line performance in Q1 2026.
Market Insights
Earnings Beat, Outlook Miss UnitedHealth Group’s latest earnings release delivered a mixed message to investors and the market’s verdict was swift.
Market Insights
Key Takeaways UnitedHealth delivered a modest Q3 earnings beat , with adjusted EPS and revenue both rising; however, growth was largely fuelled by higher premiums rather than organic expansion.
